Boston

Arrakis CEO Michael Gilman
Biotech

Drugging the undruggable and other challenges on the road to targeting RNA with pills

By Rebecca Robbins, Adam Feuerstein, and Damian Garde

Tape measure helix
Health

A new genetic test can offer clues — and only clues — to a person’s risk of obesity

By Rebecca Robbins

Biotech

A biotech startup’s lofty goal: Kill cancer with pills that target RNA instead of proteins

By Adam Feuerstein

Human embryo under microscope
Health

U.S. researcher says he’s ready to start four pregnancies with ‘three-parent’ embryos

By Emily Mullin

Unfinished bridge
Biotech

When a new biotech’s drug pipeline is more of a ‘hypeline’

By Kate Sheridan

High Blood Pressure
Health

For its next phase, the Framingham Heart Study will explore the biology of aging

By Robert Weisman — Boston Globe

Man coughing
Biotech

How one company thinks unraveling cough can provide a new way to treat pain

By Damian Garde

Amazon logo - photo illo
Business

5 names to know at Amazon: the key players behind its health care push

By Casey Ross

STAT SPOTLIGHT
Biotech

Startup Spotlight: Flagship reveals Kintai Therapeutics — yet another microbiome company

By Kate Sheridan

Mitochondrial painting
Health

Patient advocates and scientists launch push to lift ban on ‘three-parent IVF’

By Emily Mullin

Pile of mice
In the Lab

It’s just in mice! This scientist is calling out hype in science reporting

By Shraddha Chakradhar

Biotech

Latest Alnylam data underscores positive results for new RNAi drug candidate, at least for some patients

By Kate Sheridan

Can opener
In the Lab

New study reveals HIV’s vulnerabilities, opening up possibilities for complementary therapies

By Shraddha Chakradhar

Henning Jacobson newspaper clip illo
Health

Can officials require vaccinations against measles? A century-old case may give them a foothold

By Helen Branswell

TUFTS - Sackler
Special Report

‘We owe much to the Sackler family’: How gifts to a top medical school advanced the interests of Purdue Pharma

By Andrew Joseph

Boston University
Health

Zapping brain with precise electrical current boosts working memory in older adults, study finds

By Sharon Begley

Alnylam RNAi
Biotech

Regeneron to invest $800 million in Alnylam, betting on drug-making technique enabled by a Nobel-winning discovery

By Matthew Herper

John Kapoor
Pharma

At opioid racketeering trial, defense puts blame on government’s star witness

By Jonathan Saltzman — Boston Globe

Your Health Speaks
Health

In the quest to turn voice data into a depression screening tool, one startup looks to India

By Rebecca Robbins

iCarbonX offices
Business

U.S. forces health company to ditch Chinese investor, in sign of heightened concern over foreign influence

By Rebecca Robbins, Matthew Herper, and Damian Garde

Medical costs photo illustration
Pharmalot

Three drug makers settle allegations of using charities to pay kickbacks to Medicare patients

By Ed Silverman

Alexa - what are your skills
Health

Amazon Alexa is now HIPAA-compliant. Tech giant says health data can now be accessed securely

By Casey Ross

Peter Bucciarelli
Health

Hepatitis C-infected hearts and lungs can be safely transplanted, study says, opening way to more donors

By Jacquelyn Corley

DNA genome saliva kit
Health

5 burning questions for the DNA testing industry after the launch of the latest new disease risk test

By Kate Sheridan and Rebecca Robbins

Biotech

It’s only test tubes and mice, but Rubius Therapeutics hails first new data on red blood cell-derived cancer drugs

By Adam Feuerstein

Biotech

In biotech’s biggest hub, companies open their labs to an unlikely inspector: the city’s veterinarian

By Kate Sheridan

Biotech

Biogen believes failed Alzheimer’s trials may still offer clues to way forward on treatment

By Damian Garde

Cyclerion
Biotech

Maturing Ironwood is spinning off Cyclerion, its edgy, risk-taking kid brother

By Jonathan Saltzman — Boston Globe

Health

When the ‘real thing’ becomes a mirage: How patients in Alzheimer’s trials are coping with the treatment’s failure

By Andrew Joseph

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy